Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITPR3 | Q14573 | 9/20 | 0.54 |
| ▸ | ITPR2 | Q14571 | 5/20 | 0.52 |
| ▸ | ITPR1 | Q14643 | 5/20 | 0.52 |
| ▸ | INPPL1 | O15357 | 1/20 | 0.52 |
| ▸ | AKT1 | P31749 | 1/20 | 0.52 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.50 |
| ▸ | INPP5A | Q14642 | 4/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phytic Acid SCHEMBL141097 | 0.81 | ITPR3 (0.77) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Phytic Acid SCHEMBL12138455 | 0.81 | ITPR3 (0.77) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Phytic Acid SCHEMBL15374707 | 0.81 | ITPR3 (0.77) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Phytic Acid SCHEMBL9164308 | 0.81 | ITPR3 (0.77) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| SCHEMBL8467566 | 0.81 | ITPR3 (0.77) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Phytic Acid SCHEMBL1681701 | 0.81 | ITPR3 (0.77) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Phytate SCHEMBL136587 | 0.81 | ITPR3 (0.77) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Phytic Acid SCHEMBL17006482 | 0.81 | ITPR3 (0.77) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Phytic Acid SCHEMBL9741350 | 0.81 | ITPR3 (0.77) | ITPR3ITPR2ITPR1INPPL1AKT1 | |
| Phytic Acid SCHEMBL9325946 | 0.81 | ITPR3 (0.77) | ITPR3ITPR2ITPR1INPPL1AKT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240237643-A1 | COMPOSITIONS WITH VIRUCIDAL AND/OR ANTIVIRAL ACTIVITY | SYMRISE AG (DE) | 2024-07-18 | — | — | US | disclosed |
| US-20240216248-A1 | MICROBIAL GLYCOLIPIDS | ANALYTICON DISCOVERY GMBH (DE) | 2024-07-04 | — | — | US | disclosed |
| EP-4387587-A1 | COMPOSITIONS | Symrise AG (DE) | 2024-06-26 | — | — | EP | disclosed |
| WO-2024110023-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | SYMRISE AG (DE) | 2024-05-30 | — | — | WO | disclosed |
| WO-2024110515-A1 | AN ACTIVE COMPOSITION COMPRISING RETINOL | SYMRISE AG (DE) | 2024-05-30 | — | — | WO | disclosed |
| US-20240173227-A1 | A FRAGRANCE MIXTURE CONTAINING ISOCITRONELLOL | SYMRISE AG (DE) | 2024-05-30 | — | — | US | disclosed |
| WO-2024104625-A1 | A BLEND OF EMOLLIENTS | SYMRISE AG (DE) | 2024-05-23 | — | — | WO | disclosed |
| WO-2024104546-A1 | A BLEND OF EMOLLIENTS | SYMRISE AG (DE) | 2024-05-23 | — | — | WO | disclosed |
| US-20240122816-A1 | ARTICLES FOR INDIRECT TRANSFER OF COSMETIC ACTIVES TO SKIN | SYMRISE AG (DE) | 2024-04-18 | — | — | US | disclosed |
| US-20240122834-A1 | MEDICAMENT FOR PREVENTION AND TREATMENT OF HYPERPIGMENTATION | SYMRISE AG (DE) | 2024-04-18 | — | — | US | disclosed |
| WO-2006098980-A2 | OIL GELS OF CONTROLLED DISTRIBUTION BLOCK COPOLYMERS AND ESTER OILS | KRATON POLYMERS RESEARCH B.V. (NL) | 2006-09-21 | — | — | WO | disclosed |
| US-20060205904-A1 | Oil gels of controlled distribution block copolymers and ester oils | UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT | 2006-09-14 | — | — | US | disclosed |
| US-20060205849-A1 | Oil gels of controlled distribution block copolymers and ester oils | KRATON POLYMERS U.S. LLC | 2006-09-14 | — | — | US | disclosed |
| EP-1141111-B1 | GEL COMPOSITIONS | PENRECO (US) | 2005-08-03 | — | — | EP | disclosed |
| US-6881776-B2 | Gel compositions | PENRECO (US) | 2005-04-19 | — | — | US | disclosed |
| US-20050004274-A1 | Gel compositions | HEALY LIN LU (US) | 2005-01-06 | — | — | US | disclosed |
| EP-1256336-A2 | Two-phase gel composition | Penreco (US) | 2002-11-13 | — | — | EP | disclosed |
| US-20020055562-A1 | Gel compositions | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2002-05-09 | — | — | US | disclosed |
| EP-1141111-A1 | GEL COMPOSITIONS | Penreco (US) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000026285-A1 | GEL COMPOSITIONS | PENRECO (US) | 2000-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240122834-A1 | MEDICAMENT FOR PREVENTION AND TREATMENT OF HYPERPIGMENTATION | MC1R, OR51E2, TYR | ITPR3 3657/4885ITPR2 4066/4885ITPR1 4202/4885 |
| US-20240216248-A1 | MICROBIAL GLYCOLIPIDS | UGCG, SGMS1, GPR119 | ITPR3 2717/4885ITPR2 2918/4885ITPR1 3003/4885 |
| US-20240122816-A1 | ARTICLES FOR INDIRECT TRANSFER OF COSMETIC ACTIVES TO SKIN | CUTA, POLR1C, SLC16A7 | ITPR3 4315/4885ITPR2 4628/4885ITPR1 4575/4885 |
| US-20240237643-A1 | COMPOSITIONS WITH VIRUCIDAL AND/OR ANTIVIRAL ACTIVITY | ZC3HAV1, SAMHD1, ZC3HAV1L | ITPR3 2735/4885ITPR2 3434/4885ITPR1 2813/4885 |
| US-20240173227-A1 | A FRAGRANCE MIXTURE CONTAINING ISOCITRONELLOL | IPO5, OR51E2, FDFT1 | ITPR3 783/4885ITPR2 1254/4885ITPR1 987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.